Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

Although it’s possible that the FDA approval for the interim look can provide some boost and is the showstopper for any AXAL deal, I doubt it is the reason for an absence of any monetary deals. They had lots of time to strike a deal and it has not happened. The reason could be as simple as there was no Ph 2 for the adjuvant settings. Now it’s a crapshoot for any pharma to pay for it. Well, they could have taken a stake in the company but why would they do that? Advaxis is on life support and they know it. Too much risk for unknown payoff. I don’t have to talk about the ISTs as they are virtually irrelevant to the direction of this company.